Results 31 to 40 of about 224,439 (383)
Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium
Hormone Research in Paediatrics, 2019 This update, written by authors designated by multiple pediatric endocrinology societies (see List of Participating Societies) from around the globe, concisely addresses topics related to changes in GnRHa usage in children and adolescents over the last ...
Kanthi Bangalore Krishna +7 more
semanticscholar +1 more source
Gonadotropin releasing hormone agonists: Expanding vistas
Indian Journal of Endocrinology and Metabolism, 2011 Gonadotropin-releasing hormone (GnRH) agonists are derived from native GnRH by amino acid substitution which yields the agonist resistant to degradation and increases its half-life.
Navneet Magon
doaj +1 more source
JCRPE, 2021 Objective:A consensus on how to monitor girls with central precocious puberty (CPP) during gonadotropin-releasing hormone agonist (GnRHa) treatment is lacking.
Stefanie Schubert +4 more
doaj +1 more source
Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs
Frontiers in Oncology, 2019 Although significant progress has been made in the implementation of new breast cancer treatments over the last three decades, this neoplasm annually continues to show high worldwide rates of morbidity and mortality.
Maira Huerta-Reyes +6 more
semanticscholar +1 more source
Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System
Frontiers in Endocrinology, 2017 Gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone, and luteinizing hormone orchestrate the reproduction cycle and regulate the sex steroid secretion from the gonads.
Bodil Ohlsson, Bodil Ohlsson
doaj +1 more source
The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
Frontiers in Endocrinology, 2017 In several human malignant tumors of the urogenital tract, including cancers of the endometrium, ovary, urinary bladder, and prostate, it has been possible to identify expression of gonadotropin-releasing hormone (GnRH) and its receptor as part of an ...
C. Gründker, G. Emons
semanticscholar +1 more source
The use of GnRH analogs in preserving ovarian function during chemotherapy
Middle East Fertility Society Journal, 2021 Background The literature has always been controversial on the use of gonadotropin-releasing hormone agonists in preserving fertility in women of childbearing age after chemotherapy; thereby, in this article, we will be discussing its use in preserving ...
Omar M. Odeh +3 more
doaj +1 more source
Hormonal Factors Moderate the Associations Between Vascular Risk Factors and White Matter Hyperintensities [PDF]
arXiv, 2022 Objective: To examine the moderation effects of hormonal factors on the associations between vascular risk factors and white matter hyperintensities (WMH) in men and women, separately. Methods: WMH were automatically segmented and quantified in the UK Biobank dataset (N = 18,294). Generalised linear models were applied to examine 1) the main effects of
arxiv
The Role of the Brain in the Pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS). [PDF]
, 2019 Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder, affecting at least 10% of women of reproductive age. PCOS is typically characterized by the presence of at least two of the three cardinal features of hyperandrogenemia (high ...
Coutinho, Eulalia A +1 more
core +1 more source
Clinical and Experimental Reproductive Medicine, 2016 Objective To determine the preferred regimen for women with adenomyosis undergoing in vitro fertilization (IVF), we compared the IVF outcomes of fresh embryo transfer (ET) cycles with or without gonadotropin-releasing hormone (GnRH) agonist pretreatment ...
C. Park, Min Hye Choi, K. Yang, I. Song
semanticscholar +1 more source